Results 181 to 190 of about 479,258 (314)

n-3 PUFAs for depression: treatment effect or absence-of-placebo effect? [PDF]

open access: yesTransl Psychiatry, 2022
Memarpouri A   +2 more
europepmc   +1 more source

The Placebo Effect on Reading Ability [PDF]

open access: yes
openIl presente studio è nato con l’obiettivo di testare alcuni effetti fisiologici, come la dimensione della pupilla e la frequenza cardiaca, di un paio di occhiali che sono stati progettati per migliorare le capacità di lettura.
LEDRI, MARTINA
core  

Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long‐Term Multicenter Observational Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective Osteoporosis causes fractures that further increase the disease burden of rheumatoid arthritis (RA); however, osteoporosis treatment rates remain low. Although several studies have reported that biologic or targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) can prevent or improve osteoporosis in RA, our large‐scale, real ...
Takafumi Aritomi   +30 more
wiley   +1 more source

The Power of Belief: Investigating the Placebo Effect in Post-Exercise Recovery Strategies for Football Players. [PDF]

open access: yesHealthcare (Basel)
Pernigoni M   +5 more
europepmc   +1 more source

Editorial: Placebo Effect in Pain and Pain Treatment. [PDF]

open access: yesFront Pain Res (Lausanne), 2022
Bernstein MH, Blease C, Vase L.
europepmc   +1 more source

Interleukin‐2 Deprived State of Regulatory T cells and Their Recovery by Low‐Dose Interleukin‐2 in Patients With Inflammatory Myopathies

open access: yesArthritis &Rheumatology, EarlyView.
Objective Regeneration and expansion of Treg by low‐dose interleukin‐2 (IL‐2) therapy is considered a potential treatment strategy for a wide range of autoimmune diseases. To provide a pathophysiologically‐based rationale for low‐dose IL‐2 therapy, we investigated whether reversible defects in the Treg–IL‐2 axis emerge in inflammatory myopathies ...
Justus Ohmes   +10 more
wiley   +1 more source

The Placebo Effect of Insider Dealing Regulation. [PDF]

open access: yesOxf J Leg Stud
Enriques L, Alex Lee YH, Romano A.
europepmc   +1 more source

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double‐Blind, Proof‐of‐Concept Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess guselkumab + golimumab combination therapy versus guselkumab monotherapy in participants with active psoriatic arthritis (PsA) and inadequate response to tumor necrosis factor inhibitors (TNFi‐IR). Methods Adults with active TNFi‐IR PsA (three or more tender/swollen joints) were randomized (2:1) to subcutaneous guselkumab (100 mg) +
Jose U. Scher   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy